Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.
about
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEAThe clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updatesDetection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.Differentiation of tuberculous peritonitis from peritonitis carcinomatosa without surgical intervention.Pharmacokinetic studies in mice with ICI D0490, a novel recombinant ricin A-chain immunotoxin.The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer.Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancerIndependent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancerThe Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive reviewPlasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.Sensitivity estimates of blood-based tests for colorectal cancer detection: impact of overrepresentation of advanced stage disease.Comparative study of CA242 and CA19-9 in chronic pancreatitis.A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate dClinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective studyPreoperative serum levels of CEA and CA 242 in colorectal cancer.Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C.Increased expression of TBX2 is a novel independent prognostic biomarker of a worse outcome in colorectal cancer patients after curative surgery and a potential therapeutic target.Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases.Evaluation of the analytical and clinical performances of time-resolved fluoroimmunoassay for detecting carcinoma antigen 50.
P2860
Q24678824-99B157EF-2147-4F4A-BD23-0DC7344AD16DQ26865015-5D24F267-C76C-4F64-87AA-EDDA56CEF59FQ33624194-A96C2522-9676-4B3A-9E04-603AA5AB08F3Q33781698-7EEB2168-B389-4BBC-A00A-42275BA60462Q35228822-D882E25C-742F-4C82-A031-E89C5A0CF937Q35977051-2B981566-701A-401E-8DCF-BDDBCCE277CBQ36079594-EE7FCE2A-226A-4D23-804B-324B05E5A2F2Q36079626-1F5097E5-DDB9-4314-9DE3-570D39456090Q36136087-FDE9D7D2-FA0A-43C3-806B-A7C984EC00F5Q36646576-992C6B8E-A334-4BBC-8051-7F501252074CQ37362516-1930B5C7-3592-4FE6-8B28-480BE4892589Q37801547-AF135BDC-83D4-430E-A825-2855C39F1276Q39993160-1C3A7AC9-1AAF-44CA-8133-BFD95D7335B2Q41960323-688E1B51-08A4-46F1-BE07-9CB119CEEE1EQ42023730-C129E915-7BF6-44C4-A4C0-35B8A4C049AEQ42390240-A6587826-130E-4F8C-85E3-368712E145A7Q42590533-F3A892F9-86A3-416A-8D7E-AE4994D5CBBFQ46808255-3763DC9D-DE88-47E3-B226-83B4279E66C1Q47743734-E0ED30E0-24E4-44ED-8BCE-B45B8C5C2629Q51549059-EA361435-42D5-456D-A706-DE7DFD2F2E51Q53513501-F0C17B97-0F22-44A7-BFE7-EFC38376D3D8
P2860
Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Comparison of a new tumour mar ...... ) in digestive tract diseases.
@en
type
label
Comparison of a new tumour mar ...... ) in digestive tract diseases.
@en
prefLabel
Comparison of a new tumour mar ...... ) in digestive tract diseases.
@en
P2093
P2860
P356
P1476
Comparison of a new tumour mar ...... ) in digestive tract diseases.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1991.146
P407
P577
1991-04-01T00:00:00Z
P5875
P6179
1044673867